Development and characterization of effervescent floating tablet of famotidine for treatment of peptic ulcer

Authors

  • Shilpi Sahu Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001
  • Vivek Jain Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001
  • Sunil Kumar Jain Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001
  • Pushpendra Kumar Jain Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Abstract

Floating drug delivery systems (FDDS) are utilized to target drug discharge in the stomach or to the upper parts of intestine. Famotidine has been the most extensively used drug for the management of peptic ulcer for various decades. The current study concerns the development and evaluation of floating tablets of famotidine which, after oral administration, are planned to extend the gastric residence time, enhance drug bioavailability and aim the gastric ulcer. A FDDS was expanded using gas-forming agents, like sodium bicarbonate, citric acid and hydrocolloids, like hydroxypropyl methylcellulose (HPMC) and carbopol 934P. The prepared tablets were evaluated in terms of their pre-compression parameters, physical characteristics, buoyancy, buoyancy lag-time, in vitro release, and swelling index. The formulations were optimized for the different viscosity grades of HPMC, carbopol 934P and its concentrations and combinations. The consequences of the in vitro release studies demonstrated that the optimized formulation (F6) could sustain drug release (98%) for 24 h and remain buoyant for 24 hr. Optimized formulation (F6) showed no considerable change in physical appearance, drug content, total buoyancy time or in vitro dissolution study after storage at 40°C/75% RH for 3 months. Lastly the tablet formulations establish to be economical and may conquer the draw backs associated with the drug during its absorption.

Keywords: Famotidine, Floating drug delivery system, Hydrocolloids, Gastric residence time.

Keywords:

Famotidine, Floating drug delivery system, Hydrocolloids, Gastric residence time

DOI

https://doi.org/10.22270/jddt.v11i5-S.5118

Author Biographies

Shilpi Sahu, Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Vivek Jain, Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Sunil Kumar Jain, Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Pushpendra Kumar Jain, Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

References

Agyilirah GA, Green M, Ducret R. Evaluation of the gastric retention properties of a crosslinked polymer coated tablet versus those of a non-disintegrating tablets. Int J Pharm 1991; 75:241-247. https://doi.org/10.1016/0378-5173(91)90198-W

Hoffman F, Pressman JH, Code CF. Controlled entry of orally administered drugs: physiological considerations. Drug Dev Ind Pharm1983; 9:1077-1085. https://doi.org/10.3109/03639048309046314

Deshpande AA, Shah NH, Rhodes CT. Controlled release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm 1996; 22:531-539. https://doi.org/10.3109/03639049609108355

Hwang SJ, Park H, Park K. Gastric retentive drug delivery systems. Crit Rev Ther Drug 1998; 15:243-248. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v15.i3.20

Sood RP. Design of controlled release delivery systems using modified pharmacokinetic approach: a case study for drugs having a short elimination half life and a narrow therapeutic index. Int J Pharm 2003; 261:27-41. https://doi.org/10.1016/S0378-5173(03)00267-9

Singh N, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 2000; 63:235-259. https://doi.org/10.1016/S0168-3659(99)00204-7

Soppimath KS, Kulkarni RA, Rudzinski WE. Microspheres as floating drug delivery systems to increase gastric retention of drugs. Drug Met Rev 2001; 33:149-160. https://doi.org/10.1081/DMR-100104401

Rang HP, Dale M, Ritter JM, Flower RJ. Rang and Dale's. Pharmacology, 6th ed. pp. 402.

Laurence LB, Keith LP, Donald KB. Goodmann and Gilmann. The Pharmacological Basis of Therapeutics. 11th edition, 2006, pp. 1051.

Patil SC, Payghan SA, Disouza JI. Formulation and evaluation of oral disintegrating tablet of lornoxicam. Int J Pharm & Bio Archives 2011; 2(5):1518-1523.

Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage form. J Control Rel 2003; 90:143-162. https://doi.org/10.1016/S0168-3659(03)00203-7

Singh BN, Kim HK. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel 2000; 63:235-59. https://doi.org/10.1016/S0168-3659(99)00204-7

Al-Omar MA, Al-Mohizea AM. Famotidine, analytical profile. In: Brittain HG, editor. Profiles of drug substances, excipients and related methodology. Burlington: Academic Press; 2009, pp. 115-151. https://doi.org/10.1016/S1871-5125(09)34003-0

Muzib YI, Ch Rekha. Development and evaluation of mineral oil entrapped emulsion gel beads of famotidine. Int J Pharmacol Technol 2011; 3(2):83-90.

Babu VR, Areefulla SH, Mallikarjun V, et al., Solubility and dissolution enhancement: an overview. J Pharm Res 2010; 3(1):141-145.

Indian Pharmacopoeia, Government of India ministry of health and family welfare, The controller of Publication, Delhi, 4th ed, 1996.

Sinko PJ, Physical Pharmacy and Pharmaceutical Sciences, Lippincott Williams and Wilkins, 5th Edition, 2006.

Chein YW. Novel drug delivery systems, Marcel Dekker, INC, 2nd edition, 1992, pp. 140.

Liberman HA, Lachman L, Schwartz JB. Pharmaceutical dosage forms: Tablets, 3rd edition, Marcel Dekker, New York, 1990.

Indian Pharmacopoeia, The Controller of Publications: Delhi, Vol. II, 1996; pp: 734-36.

Banker GS, Anderson NR. In The Theory and Practice of Industrial Pharmacy, Lachmann L, Liberman HA, Kaing JL. Eds. Varghese Publishing House: Bombay, 1987; pp. 297-99.

Rosa M, Zia H, Rhodes T. Dosing and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm 1994; 105:65-70. https://doi.org/10.1016/0378-5173(94)90236-4

Published

2021-12-06
Statistics
Abstract Display: 924
PDF Downloads: 732
PDF Downloads: 134

How to Cite

1.
Sahu S, Jain V, Jain SK, Jain PK. Development and characterization of effervescent floating tablet of famotidine for treatment of peptic ulcer. J. Drug Delivery Ther. [Internet]. 2021 Dec. 6 [cited 2025 Nov. 13];11(5-S):119-23. Available from: https://jddtonline.info/index.php/jddt/article/view/5118

How to Cite

1.
Sahu S, Jain V, Jain SK, Jain PK. Development and characterization of effervescent floating tablet of famotidine for treatment of peptic ulcer. J. Drug Delivery Ther. [Internet]. 2021 Dec. 6 [cited 2025 Nov. 13];11(5-S):119-23. Available from: https://jddtonline.info/index.php/jddt/article/view/5118

Most read articles by the same author(s)

> >>